MALENKA ROBERT C. sold 4.2% of their position (14.20K shares) of MAPLIGHT THERAPEUTICS, INC. on the open market
Open‑market sale worth $260.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 2/24/2026ACC: 0002021198-26-000011
Director
Since Feb 2026
-14.20K
Net shares
Net seller
$260.4K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
14.20K disposed
Non-Derivative Transactions4
Voting Common Stock
Direct
Shares
−2.19K
Price / share
$18.03
Trade value
$39.58K
% of position
0.6%
2/20/2026
339.25K→337.06K
Voting Common Stock
Direct
Shares
−10.79K
Price / share
$18.39
Trade value
$198.39K
% of position
3.2%
2/23/2026
337.06K→326.27K
Voting Common Stock
Direct
Shares
−476.00
Price / share
$19.06
Trade value
$9.07K
% of position
0.1%
2/23/2026
326.27K→325.80K
Voting Common Stock
Direct
Shares
−736.00
Price / share
$18.15
Trade value
$13.36K
% of position
0.2%
2/24/2026
325.80K→325.06K
Total
Net shares
−14.20K
Net value
-$260.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Voting Common Stock Direct | 2/20/2026 | S · Sale | −2.19K | $18.03 | $39.58K | 0.6% | 339.25K | 337.06K |
| Voting Common Stock Direct | 2/23/2026 | S · Sale | −10.79K | $18.39 | $198.39K | 3.2% | 337.06K | 326.27K |
| Voting Common Stock Direct | 2/23/2026 | S · Sale | −476.00 | $19.06 | $9.07K | 0.1% | 326.27K | 325.80K |
| Voting Common Stock Direct | 2/24/2026 | S · Sale | −736.00 | $18.15 | $13.36K | 0.2% | 325.80K | 325.06K |
| Total | −14.20K | -$260.40K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Voting Common Stock
IndirectShares owned31.67K
Total
31.67K indirect31.67K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Voting Common Stock | 31.67K | Indirect |
| Total | 31.67K | 31.67K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported